HighTower Advisors’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-3,128
| Closed | -$308K | – | 3821 |
|
|
2025
Q2 | $308K | Buy |
3,128
+553
| +21% | +$52.3K | ﹤0.01% | 2909 |
|
|
2025
Q1 | $238K | Sell |
2,575
-167
| -6% | -$15.4K | ﹤0.01% | 3049 |
|
|
2024
Q4 | $249K | Sell |
2,742
-731
| -21% | -$67.1K | ﹤0.01% | 3026 |
|
|
2024
Q3 | $337K | Sell |
3,473
-21
| -0.6% | -$2.05K | ﹤0.01% | 2735 |
|
|
2024
Q2 | $320K | Buy |
3,494
+27
| +0.8% | +$2.5K | ﹤0.01% | 2660 |
|
|
2024
Q1 | $319K | Sell |
3,467
-699
| -17% | -$65.5K | ﹤0.01% | 2630 |
|
|
2023
Q4 | $396K | Buy |
4,166
+112
| +3% | +$10.5K | ﹤0.01% | 2490 |
|
|
2023
Q3 | $374K | Sell |
4,054
-3,812
| -48% | -$352K | ﹤0.01% | 2427 |
|
|
2023
Q2 | $717K | Buy |
7,866
+890
| +13% | +$73K | ﹤0.01% | 1959 |
|
|
2023
Q1 | $518K | Buy |
6,976
+899
| +15% | +$77.8K | ﹤0.01% | 2082 |
|
|
2022
Q4 | $519K | Sell |
6,077
-719
| -11% | -$64.8K | ﹤0.01% | 2108 |
|
|
2022
Q3 | $660K | Sell |
6,796
-508
| -7% | -$60.6K | ﹤0.01% | 1851 |
|
|
2022
Q2 | $766K | Sell |
7,304
-315
| -4% | -$40.2K | ﹤0.01% | 1800 |
|
|
2022
Q1 | $1.31M | Buy |
7,619
+2,193
| +40% | +$328K | ﹤0.01% | 1601 |
|
|
2021
Q4 | $869K | Buy |
5,426
+1,021
| +23% | +$164K | ﹤0.01% | 1839 |
|
|
2021
Q3 | $654K | Buy |
4,405
+135
| +3% | +$28.1K | ﹤0.01% | 1896 |
|
|
2021
Q2 | $1.03M | Buy |
4,270
+673
| +19% | +$177K | ﹤0.01% | 1620 |
|
|
2021
Q1 | $957K | Buy |
3,597
+887
| +33% | +$250K | ﹤0.01% | 1592 |
|
|
2020
Q4 | $802K | Buy |
2,710
+26
| +1% | +$6.67K | ﹤0.01% | 1378 |
|
|
2020
Q3 | $629K | Buy |
2,684
+42
| +2% | +$9.55K | ﹤0.01% | 1468 |
|
|
2020
Q2 | $526K | Buy |
2,642
+403
| +18% | +$75.2K | ﹤0.01% | 1431 |
|
|
2020
Q1 | $408K | Buy |
+2,239
| New | +$398K | ﹤0.01% | 1419 |
|
|
2019
Q4 | – | Sell |
-1,939
| Closed | -$260K | – | 2317 |
|
|
2019
Q3 | $260K | Buy |
1,939
+81
| +4% | +$10.5K | ﹤0.01% | 1896 |
|
|
2019
Q2 | $231K | Buy |
+1,858
| New | +$220K | ﹤0.01% | 1960 |
|
Other funds holding AMED
IA
MCI
HNB
HighTower Advisors's AMED Position: Q3 2025 in Review
HighTower Advisors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 3,128 shares — an estimated $308K sold.
HighTower Advisors first reported a position in AMED in Q2 2019 and held it in 24 quarters. The position peaked at $1.31M in Q1 2022. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- HighTower Advisors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- HighTower Advisors sold 3,128 Amedisys shares in Q3 2025, an estimated $308K.
- HighTower Advisors first reported a position in Amedisys in Q2 2019 and held it in 24 quarters.
- HighTower Advisors's Amedisys position peaked at $1.31M in Q1 2022.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on HighTower Advisors's 13F filing for Q3 2025, filed 7 Nov 2025.